Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with...

Patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin...

Sickle cell disease is a complex, systemic disorder, and healthcare staff awareness of its risks and...

The guideline notes that the risk of recurrent venous thromboembolism is increased at least twofold in...

Mr Brian O’Mahony, Chief Executive, Irish Haemophilia Society, recounts his experience of participating in a gene...

In this issue, highlights from the American Society of Clinical Oncology and European Haematology Association Annual...

This CPD module gives a detailed overview of the presentation, diagnosis, and latest treatment options...

In this issue, highlights from the 2023 Gathering Around Cancer as well as national and international...

Acute myeloid leukaemia (AML) is an aggressive form of blood cancer that is derived from the...

Welcome to the latest edition of Update Oncology and Haematology. Despite the ongoing pressure on healthcare...

Acnew study published in Blood Advances demonstrates that patients with haematological...

Chimeric antigen receptor (CAR) T-cell therapy is a highly personalised technology whereby a patient’s...